ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML
- PMID: 17027752
- DOI: 10.1016/j.yexcr.2006.06.037
ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML
Abstract
The ZNF198/FGFR1 fusion gene in atypical myeloproliferative disease produces a constitutively active cytoplasmic tyrosine kinase, unlike ZNF198 which is normally a nuclear protein. We have now shown that the ZNF198/FGFR1 fusion kinase interacts with the endogenous ZNF198 protein suggesting that the function of ZNF198 may be compromised in cells expressing it. Little is currently known about the endogenous function of ZNF198 and to investigate this further we performed a yeast two-hybrid analysis and identified SUMO-1 as a binding partner of ZNF198. These observations were confirmed using co-immunoprecipitation which demonstrated that ZNF198 is covalently modified by SUMO-1. Since many of the SUMO-1-modified proteins are targeted to the PML nuclear bodies we used confocal microscopy to show that SUMO-1, PML and ZNF198 colocalize to punctate structures, shown by immunocytochemistry to be PML bodies. Using co-immunoprecipitation we now show that PML and sumoylated ZNF198 can be found in a protein complex in the cell. Mutation of the SUMO-1 binding site in wild-type ZNF198 resulted in loss of distinct PML bodies, reduced PML levels and a more dispersed nuclear localization of the PML protein. In cells expressing ZNF198/FGFR1, which also lack the SUMO-1 binding site, SUMO-1 is preferentially localized in the cytoplasm, which is associated with loss of distinct PML bodies. Recently, arsenic trioxide (ATO) was proposed as an alternative therapy for APL that was resistant to traditional therapy. Treatment of cells expressing ZNF198/FGFR1 with ATO demonstrated reduced autophosphorylation of the ZNF198/FGFR1 protein and induced apoptosis, which is not seen in cells expressing wild-type ZNF198. Overall our results suggest that the sumoylation of ZNF198 is important for PML body formation and that the abrogation of sumoylation of ZNF198 in ZNF198/FGFR1 expressing cells may be an important mechanism in cellular transformation.
Similar articles
-
Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.Blood. 2006 May 1;107(9):3693-9. doi: 10.1182/blood-2005-04-1505. Epub 2006 Jan 12. Blood. 2006. PMID: 16410451 Free PMC article.
-
Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.J Biol Chem. 2009 Jun 12;284(24):16595-16608. doi: 10.1074/jbc.M109.006387. Epub 2009 Apr 20. J Biol Chem. 2009. PMID: 19380586 Free PMC article.
-
Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.Oncogene. 2005 Aug 18;24(35):5401-13. doi: 10.1038/sj.onc.1208714. Oncogene. 2005. PMID: 15940266
-
SUMO: of branched proteins and nuclear bodies.Oncogene. 2001 Oct 29;20(49):7243-9. doi: 10.1038/sj.onc.1204758. Oncogene. 2001. PMID: 11704852 Review.
-
Role and fate of PML nuclear bodies in response to interferon and viral infections.Oncogene. 2001 Oct 29;20(49):7274-86. doi: 10.1038/sj.onc.1204854. Oncogene. 2001. PMID: 11704856 Review.
Cited by
-
On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.Biomolecules. 2023 Dec 18;13(12):1805. doi: 10.3390/biom13121805. Biomolecules. 2023. PMID: 38136675 Free PMC article.
-
ZMYM2 controls human transposable element transcription through distinct co-regulatory complexes.Elife. 2023 Nov 7;12:RP86669. doi: 10.7554/eLife.86669. Elife. 2023. PMID: 37934570 Free PMC article.
-
Novel mutation c.2090_2091del in neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities in an 18.5-mo-old boy: A case report.World J Clin Cases. 2023 Jun 6;11(16):3891-3898. doi: 10.12998/wjcc.v11.i16.3891. World J Clin Cases. 2023. PMID: 37383123 Free PMC article.
-
The interactions between PML nuclear bodies and small and medium size DNA viruses.Virol J. 2023 May 1;20(1):82. doi: 10.1186/s12985-023-02049-4. Virol J. 2023. PMID: 37127643 Free PMC article. Review.
-
Keeping up with the condensates: The retention, gain, and loss of nuclear membrane-less organelles.Front Mol Biosci. 2022 Sep 20;9:998363. doi: 10.3389/fmolb.2022.998363. eCollection 2022. Front Mol Biosci. 2022. PMID: 36203874 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
